These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 27356647)

  • 1. [Safety and efficacy of preoperative induction therapy using a single high dose ATG-F in renal transplantation: a meta-analysis of randomized controlled trials].
    Yin H; Xu Y; Zhang Q; Xue WR; Zhang ZJ; Zeng S; Hu XP
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(22):1773-7. PubMed ID: 27356647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction with and without antithymocyte globulin combined with cyclosporine/tacrolimus-based immunosuppression in renal transplantation: a meta-analysis of randomized controlled trials.
    Tian JH; Wang X; Yang KH; Liu AP; Luo XF; Zhang J
    Transplant Proc; 2009 Nov; 41(9):3671-6. PubMed ID: 19917365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.
    Hill P; Cross NB; Barnett AN; Palmer SC; Webster AC
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004759. PubMed ID: 28073178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis on the Safety and Efficacy of the Reperfusion Use of a Single High Dose of Anti-T-Lymphocyte Globulin Fresenius in Kidney Transplantation.
    Du X; Wang W; Sun ZJ; Su LL; Zhang XD
    Transplant Proc; 2016; 48(6):2017-22. PubMed ID: 27569938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alemtuzumab versus antithymocyte globulin induction therapies in kidney transplantation patients: A systematic review and meta-analysis of randomized controlled trials.
    Zheng J; Song W
    Medicine (Baltimore); 2017 Jul; 96(28):e7151. PubMed ID: 28700465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and safety of alemtuzumab and daclizumab versus antithymocyte globulin during organ transplantation: a meta-analysis.
    Hao WJ; Zong HT; Cui YS; Zhang Y
    Transplant Proc; 2012 Dec; 44(10):2955-60. PubMed ID: 23195005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basiliximab or antithymocyte globulin for induction therapy in kidney transplantation: a meta-analysis.
    Liu Y; Zhou P; Han M; Xue CB; Hu XP; Li C
    Transplant Proc; 2010 Jun; 42(5):1667-70. PubMed ID: 20620496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction therapy of basiliximab versus antithymocyte globulin in renal allograft: a systematic review and meta-analysis.
    Wang K; Xu X; Fan M
    Clin Exp Nephrol; 2018 Jun; 22(3):684-693. PubMed ID: 28986715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymoglobulin vs. ATG-Fresenius as Induction Therapy in Kidney Transplantation: A Bayesian Network Meta-Analysis of Randomized Controlled Trials.
    Song T; Yin S; Li X; Jiang Y; Lin T
    Front Immunol; 2020; 11():457. PubMed ID: 32318057
    [No Abstract]   [Full Text] [Related]  

  • 10. Effectiveness of Antithymocyte Globulin Induction Dosing Regimens in Kidney Transplantation Patients: A Network Meta-analysis.
    Lee JH; Kim KY; Song JH; Jhee JH; Kim YJ; Park WY; Kim JK; Lee SW; Hwang SD
    Transplant Proc; 2019 Oct; 51(8):2606-2610. PubMed ID: 31439331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective comparison of the efficacy and safety in kidney transplant recipients with basiliximab and anti-thymocyte globulin.
    Wang W; Yin H; Li XB; Hu XP; Yang XY; Liu H; Ren L; Wang Y; Zhang XD
    Chin Med J (Engl); 2012 Mar; 125(6):1135-40. PubMed ID: 22613543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One year results of preoperative single bolus ATG-Fresenius induction therapy in sensitized renal transplant recipients.
    Wang D; Chen JH; Wu WZ; Yang SL; Wu GJ; Wang H; Tan JM
    Transplant Proc; 2007; 39(1):69-72. PubMed ID: 17275476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alemtuzumab induction therapy in highly sensitized kidney transplant recipients.
    Lü TM; Yang SL; Wu WZ; Tan JM
    Chin Med J (Engl); 2011 Mar; 124(5):664-8. PubMed ID: 21518554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved long-term survival after intra-operative single high-dose ATG-Fresenius induction in renal transplantation: a single centre experience.
    Kaden J; May G; Völp A; Wesslau C
    Ann Transplant; 2009; 14(3):7-17. PubMed ID: 19644154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basiliximab as an alternative to antithymocyte globulin for early immunosuppression in lung transplantation.
    Clinckart F; Bulpa P; Jamart J; Eucher P; Delaunois L; Evrard P
    Transplant Proc; 2009 Mar; 41(2):607-9. PubMed ID: 19328937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithymocyte globulin induction therapy adjusted for immunologic risk after heart transplantation.
    Czer LS; Phan A; Ruzza A; Rafiei M; Setareh-Shenas S; Caceres M; Awad M; Soliman C; Mirocha J; De Robertis M; Kass RM; Trento A
    Transplant Proc; 2013; 45(6):2393-8. PubMed ID: 23953554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rabbit antithymocyte globulin compared with basiliximab in kidney transplantation: a single-center study.
    Kim JM; Jang HR; Kwon CH; Huh WS; Kim GS; Kim SJ; Joh JW; Oh HY
    Transplant Proc; 2012 Jan; 44(1):167-70. PubMed ID: 22310606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-bolus high-dose ATG for prophylaxis of rejection in renal transplantation--a prospective, randomized study.
    Yussim A; Shapira Z
    Transpl Int; 2000; 13 Suppl 1():S293-4. PubMed ID: 11112016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Influence of Antithymocyte Globulin Dose on the Incidence of CMV Infection in High-risk Kidney Transplant Recipients Without Pharmacological Prophylaxis.
    de Paula MI; Bae S; Shaffer AA; Garonzik-Wang J; Felipe CR; Cristelli MP; Waldram MM; Massie AB; Medina-Pestana J; Segev DL; Tedesco-Silva H
    Transplantation; 2020 Oct; 104(10):2139-2147. PubMed ID: 31978003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alemtuzumab induction in renal transplantation: a meta-analysis and systemic review.
    Zhang X; Huang H; Han S; Fu S; Wang L
    Transpl Immunol; 2012 Oct; 27(2-3):63-8. PubMed ID: 22960043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.